191 related articles for article (PubMed ID: 18467491)
1. Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8.
Wu K; Katiyar S; Li A; Liu M; Ju X; Popov VM; Jiao X; Lisanti MP; Casola A; Pestell RG
Proc Natl Acad Sci U S A; 2008 May; 105(19):6924-9. PubMed ID: 18467491
[TBL] [Abstract][Full Text] [Related]
2. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth.
Wu K; Li A; Rao M; Liu M; Dailey V; Yang Y; Di Vizio D; Wang C; Lisanti MP; Sauter G; Russell RG; Cvekl A; Pestell RG
Mol Cell Biol; 2006 Oct; 26(19):7116-29. PubMed ID: 16980615
[TBL] [Abstract][Full Text] [Related]
3. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
4. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation.
Wu K; Chen K; Wang C; Jiao X; Wang L; Zhou J; Wang J; Li Z; Addya S; Sorensen PH; Lisanti MP; Quong A; Ertel A; Pestell RG
Cancer Res; 2014 Feb; 74(3):829-39. PubMed ID: 24335958
[TBL] [Abstract][Full Text] [Related]
5. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.
Popov VM; Zhou J; Shirley LA; Quong J; Yeow WS; Wright JA; Wu K; Rui H; Vadlamudi RK; Jiang J; Kumar R; Wang C; Pestell RG
Cancer Res; 2009 Jul; 69(14):5752-60. PubMed ID: 19605405
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer.
Chen K; Wu K; Gormley M; Ertel A; Wang J; Zhang W; Zhou J; Disante G; Li Z; Rui H; Quong AA; McMahon SB; Deng H; Lisanti MP; Wang C; Pestell RG
Oncotarget; 2013 Jun; 4(6):923-35. PubMed ID: 23798621
[TBL] [Abstract][Full Text] [Related]
7. DACH1 suppresses breast cancer as a negative regulator of CD44.
Xu H; Yu S; Yuan X; Xiong J; Kuang D; Pestell RG; Wu K
Sci Rep; 2017 Jun; 7(1):4361. PubMed ID: 28659634
[TBL] [Abstract][Full Text] [Related]
8. Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.
Ji S; Zhang W; Zhang X; Hao C; Hao A; Gao Q; Zhang H; Sun J; Hao J
Oncotarget; 2016 Aug; 7(31):49411-49424. PubMed ID: 27384482
[TBL] [Abstract][Full Text] [Related]
9. DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.
Liu Q; Li A; Yu S; Qin S; Han N; Pestell RG; Han X; Wu K
J Hematol Oncol; 2018 Apr; 11(1):53. PubMed ID: 29636079
[TBL] [Abstract][Full Text] [Related]
10. Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth.
Wu K; Liu M; Li A; Donninger H; Rao M; Jiao X; Lisanti MP; Cvekl A; Birrer M; Pestell RG
Mol Biol Cell; 2007 Mar; 18(3):755-67. PubMed ID: 17182846
[TBL] [Abstract][Full Text] [Related]
11. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling.
Yu Z; Willmarth NE; Zhou J; Katiyar S; Wang M; Liu Y; McCue PA; Quong AA; Lisanti MP; Pestell RG
Proc Natl Acad Sci U S A; 2010 May; 107(18):8231-6. PubMed ID: 20406904
[TBL] [Abstract][Full Text] [Related]
12. The endogenous cell-fate factor dachshund restrains prostate epithelial cell migration via repression of cytokine secretion via a cxcl signaling module.
Chen K; Wu K; Jiao X; Wang L; Ju X; Wang M; Di Sante G; Xu S; Wang Q; Li K; Sun X; Xu C; Li Z; Casimiro MC; Ertel A; Addya S; McCue PA; Lisanti MP; Wang C; Davis RJ; Mardon G; Pestell RG
Cancer Res; 2015 May; 75(10):1992-2004. PubMed ID: 25769723
[TBL] [Abstract][Full Text] [Related]
13. [Knockdown of dachshund homolog 1 (DACH1) promotes cell apoptosis and inhibits the invasion and migration abilities of Capan-1 pancreatic cancer cells].
Bu X; Wang C; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1217-22. PubMed ID: 27609579
[TBL] [Abstract][Full Text] [Related]
14. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
[TBL] [Abstract][Full Text] [Related]
15. DACH1 regulates macrophage activation and tumour progression in hypopharyngeal squamous cell carcinoma.
Li W; Xu L; Cao J; Ge J; Liu X; Liu P; Teng Y; Wang S; Sun Y; Liu M; Tian L
Immunology; 2023 Oct; 170(2):253-269. PubMed ID: 37243970
[TBL] [Abstract][Full Text] [Related]
16. DACH1 inhibits SNAI1-mediated epithelial-mesenchymal transition and represses breast carcinoma metastasis.
Zhao F; Wang M; Li S; Bai X; Bi H; Liu Y; Ao X; Jia Z; Wu H
Oncogenesis; 2015 Mar; 4(3):e143. PubMed ID: 25775416
[TBL] [Abstract][Full Text] [Related]
17. Transcription elongation regulator 1 is a co-integrator of the cell fate determination factor Dachshund homolog 1.
Zhou J; Liu Y; Zhang W; Popov VM; Wang M; Pattabiraman N; Suñé C; Cvekl A; Wu K; Jiang J; Wang C; Pestell RG
J Biol Chem; 2010 Dec; 285(51):40342-50. PubMed ID: 20956529
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
[TBL] [Abstract][Full Text] [Related]
19. Dachshund binds p53 to block the growth of lung adenocarcinoma cells.
Chen K; Wu K; Cai S; Zhang W; Zhou J; Wang J; Ertel A; Li Z; Rui H; Quong A; Lisanti MP; Tozeren A; Tanes C; Addya S; Gormley M; Wang C; McMahon SB; Pestell RG
Cancer Res; 2013 Jun; 73(11):3262-74. PubMed ID: 23492369
[TBL] [Abstract][Full Text] [Related]
20. DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling.
Han N; Yuan X; Wu H; Xu H; Chu Q; Guo M; Yu S; Chen Y; Wu K
Oncotarget; 2015 Mar; 6(8):5877-88. PubMed ID: 25788272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
